Lacticaseibacillus rhamnosus CP-1 mitigates LPS-induced acute lung injury in mice via TLR/NF-κB pathway and gut microbiota modulation

This publication has 57 references indexed in Scilit:

• Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1
  Cellular Signalling, 2023
• Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention
  Revista Brasileira de Farmacognosia, 2023
• Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2
  Probiotics and Antimicrobial Proteins, 2022
• Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
  Chemico-Biological Interactions, 2022
• The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
  Critical Care Clinics, 2021
• The Preventive Effects of Lactobacillus casei on Acute Lung Injury Induced by Lipopolysaccharide
  Indian Journal of Microbiology, 2021
• Myeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease
  Clinica Chimica Acta, 2019
• ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)
  2017
• Mechanistic role of cytochrome P450 (CYP)1B1 in oxygen-mediated toxicity in pulmonary cells: A novel target for prevention of hyperoxic lung injury
  Biochemical and Biophysical Research Communications, 2016
• Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function
  Inflammation Research, 2010